SARS-CoV-2 incidence and vaccine escape Reply

被引：2

作者：

Spinelli, Matthew A. ^{[1
]}

Rutherford, George ^{[2
]}

Gandhi, Monica ^{[1
]}

机构：

[1] Univ Calif San Francisco, Div HIV Infect Dis & Global Med, San Francisco, CA 94110 USA

[2] Univ Calif San Francisco, Dept Epidemiol, San Francisco, CA 94110 USA

来源：

LANCET INFECTIOUS DISEASES | 2021年 / 21卷 / 07期

关键词：

D O I：

10.1016/S1473-3099(21)00210-3

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：915 / 916

页数：2

共 50 条

[1] SARS-CoV-2 incidence and vaccine escape
Thompson, Robin N.
Hill, Edward M.
Gog, Julia R.
[J]. LANCET INFECTIOUS DISEASES, 2021, 21 (07): : 913 - 914
[2] SARS-CoV-2 Omicron variant: Immune escape and vaccine development
Ao, Danyi
Lan, Tianxia
He, Xuemei
Liu, Jian
Chen, Li
Baptista-Hon, Daniel T.
Zhang, Kang
Wei, Xiawei
[J]. MEDCOMM, 2022, 3 (01):
[3] Vaccine Breakthrough Infections with SARS-CoV-2 Variants REPLY
Blachere, Nathalie E.
Hacisuleyman, Ezgi
Darnell, Robert B.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021,
[4] Vaccine Breakthrough Infections with SARS-CoV-2 Variants REPLY
Blachere, Nathalie E.
Hacisuleyman, Ezgi
Darnell, Robert B.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (02):
[5] Sars-escape network for escape prediction of SARS-COV-2
Bist, Prem Singh
Tayara, Hilal
Chong, Kil To
[J]. BRIEFINGS IN BIOINFORMATICS, 2023, 24 (03)
[6] The outbreak of SARS-CoV-2 Omicron lineages, immune escape, and vaccine effectivity
Zhou, Yongbing
Zhi, Huilin
Teng, Yong
[J]. JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (01)
[7] SARS-CoV-2 vaccines: evolution and escape
Rivero, Ricardo H.
Gonzalez, Marco
Mattar, Salim
[J]. REVISTA MVZ CORDOBA, 2021, 26 (03)
[8] SARS-CoV-2 mucosal vaccine
Stephanie Houston
[J]. Nature Immunology, 2023, 24 : 1 - 1
[9] Inactivated vaccine for SARS-CoV-2
Emma Risson
[J]. Nature Reviews Immunology, 2020, 20 : 353 - 353
[10] SARS-CoV-2 mucosal vaccine
Houston, Stephanie
[J]. NATURE IMMUNOLOGY, 2023, 24 (01) : 1 - 1